Report From the Second Global Scientific Conference on Clinical Trial Design and Outcome Measures for RDH12-Associated Inherited Retinal Degeneration.

Silvia CeroliniJean BennettBart P LeroyTodd DurhamCourtney CoatesMathew T PletcherSue LaceyTomas S Aleman

Published in: Translational vision science & technology (2024)

A multi-stakeholder, patient centric approach will be critical to the design of future successful clinical trials with outcome measures relevant to the RDH12-IRD population.

Keyphrases

clinical trial
phase ii
open label
case report
optical coherence tomography
double blind
diabetic retinopathy
study protocol
phase iii
current status
randomized controlled trial
placebo controlled